Study start-up sets the foundation for success of your clinical trial. There are many considerations for vendor selection and partnerships during development and start-up. However, with these come numerous challenges such as complex protocols, gaps in site expectations, problems with enrollment and retention and more.

To combat these challenges and improve the chance for success there are several important concepts to keep in mind in the context of decentralized trials. In this new webinar, featuring expert speakers Marina Acosta Enslen, Director, Clinical Management, Rho and Mark Wilson, Manager, Study Start-Up Services, Rho, we will discuss the importance of study startup in decentralized trials to establish:

  • Patient centricity
  • Ease of enrollment
  • Risk mitigation Preserving data integrity